House Republicans Aim To Eliminate Tax Credits For Orphan Drugs
For more than three decades, pharmaceutical companies have claimed a 50 percent tax credit for the cost of clinical trials of drugs for rare diseases. The credit is now in jeopardy.
Read more on NPR
November 4, 2017 at 12:30AM
Health Care
Thứ Ba, 7 tháng 11, 2017
Đăng ký:
Đăng Nhận xét (Atom)
0 nhận xét:
Đăng nhận xét